SCHEMBL1615068

SCHEMBL1615068

O=C(NCc1cc(=O)n2nc(-c3ccc(Cl)cc3)c(-c3cccs3)c2[nH]1)C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.37
POLB P06746 5/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
PLEC Q15149 1/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2B Q13224 2/20 0.35
ARF6 P62330 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
STAT6 P42226 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRA4 P48169 1/20 0.33
NTRK1 P04629 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15909027 0.85 POLB (0.41) MAPK14POLBMAPTGRIN1GRIN2B
SCHEMBL1614902 0.84 HPGD (0.35) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL15926321 0.84 MAPK14 (0.40) MAPK14POLBMAPTMEN1KMT2A
SCHEMBL1279271 0.83 MAPK14 (0.41) MAPK14POLBMAPTMEN1KMT2A
SCHEMBL1279158 0.80 ADORA3 (0.39) MAPK14POLBMAPTMEN1KMT2A
SCHEMBL1614984 0.74 ARF6 (0.35) ARF6
SCHEMBL15926359 0.74 KDM4E (0.35) POLBMAPTALDH1A1LMNASMN1; SMN2
SCHEMBL1615074 0.71 KCNQ3 (0.38) MAPK14POLBMAPTMEN1KMT2A
SCHEMBL15909005 0.71 HDAC1 (0.40) POLBMEN1KMT2AALDH1A1LMNA
SCHEMBL15909062 0.71 NPC1 (0.38) POLBMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 MAPK14 2408/4885POLB 2845/4885MAPT 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.